WITHDRAWAL OF ADALIMUMAB IN EARLY RHEUMATOID ARTHRITIS PATIENTS WHO ATTAINED STABLE LOW DISEASE ACTIVITY WITH ADALIMUMAB PLUS METHOTREXATE: RESULTS OF A PHASE 4, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引：0

作者：

Kavanaugh, Arthur ^{[1
]}

Emery, Paul ^{[2
]}

Fleischmann, Roy ^{[3
]}

van Vollenhoven, Ronald ^{[4
]}

Pavelka, Karel ^{[5
]}

Durez, Patrick ^{[6
]}

Guerette, Benoit ^{[7
]}

Santra, Sourav ^{[8
]}

Redden, Laura ^{[8
]}

Kupper, Hartmut ^{[9
]}

Smolen, Josef S. ^{[10
,11
]}

机构：

[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA

[2] Leeds Teaching Hosp, Dept Rheumatol, Leeds, W Yorkshire, England

[3] Univ Texas SW Med Ctr Dallas, Dept Rheumatol, Dallas, TX 75390 USA

[4] Karolinska Inst, Dept Rheumatol, Stockholm, Sweden

[5] Charles Univ Prague, Dept Rheumatol, Prague, Czech Republic

[6] Catholic Univ Louvain, Dept Rheumatol, B-1348 Louvain, Belgium

[7] Abbott, GPRD, Rungis, France

[8] Abbott, GPRD, Abbott Pk, IL USA

[9] Abbott, GPRD, Ludwigshafen, Germany

[10] Med Univ Vienna, Dept Rheumatol, Vienna, Austria

[11] Hietzing Hosp, Vienna, Austria

来源：

RHEUMATOLOGY | 2012年 / 51卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：29 / 30

页数：2

共 50 条

[11] Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis - A double-blind, randomized, placebo-controlled trial
van Dongen, Henrike
van Aken, Jill
Lard, Leroy R.
Visser, Karen
Ronday, H. Karel
Hulsmans, Harry M. J.
Speyer, Irene
Westedt, Marie-Louise
Peeters, Andre J.
Allaart, Cornelia F.
Toes, Rene E. M.
Breedveld, Ferdinand C.
Huizinga, Tom W. J.
ARTHRITIS AND RHEUMATISM, 2007, 56 (05): : 1424 - 1432
[12] The PREMIER study - A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
Breedveld, FC
Weisman, MH
Kavanaugh, AF
Cohen, SB
Pavelka, K
van Vollenhoven, R
Sharp, J
Perez, JL
Spencer-Green, GT
ARTHRITIS AND RHEUMATISM, 2006, 54 (01): : 26 - 37
[13] ADJUVITE: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF ADALIMUMAB IN JUVENILE IDIOPATHIC ARTHRITIS ASSOCIATED UVEITIS
Quartier, P.
Despert, V.
Poignant, S.
Elie, C.
Kone-Paut, I.
Belot, A.
Kodjikian, L.
Monnet, D.
Weber, M.
Bodaghi, B.
Baptiste, A.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 273 - 273
[14] EFFICACY OF ADDITION, OR CONTINUATION, OF ADALIMUMAB IN PATIENTS WHO DID NOT ACHIEVE STABLE LOW DISEASE ACTIVITY WITH METHOTREXATE OR ADALIMUMAB PLUS METHOTREXATE IN THE OPTIMA STUDY
Kavanaugh, A.
Fleischmann, R.
Emery, P.
van Vollenhoven, R.
Florentinus, S.
Shaw, J. W.
Santra, S.
Kupper, H.
Redden, L.
Smolen, J.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 511 - 512
[15] Patient-Reported Outcomes in Early Rheumatoid Arthritis Patients Failing to Achieve Stable Low Disease Activity: Comparing Addition of Adalimumab to Methotrexate Monotherapy with Maintenance On Adalimumab Plus Methotrexate.
Kavanaugh, Arthur
van Vollenhoven, Ronald F.
Emery, Paul
Shaw, James W.
Cifaldi, Mary A.
Florentinus, Stefan
Smolen, Josef S.
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S162 - S163
[16] A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib to Placebo and to Adalimumab, in Patients with Active Rheumatoid Arthritis with Inadequate Response to Methotrexate
Fleischmann, Roy
Pangan, Aileen L.
Mysler, Eduardo
Bessette, Louis
Peterfy, Charles
Durez, Patrick
Ostor, Andrew
Li, Yihan
Zhou, Yijie
Othman, Ahmed A.
Song, In-Ho
Genovese, Mark C.
ARTHRITIS & RHEUMATOLOGY, 2018, 70
[17] Concomitant iguratimod therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate: a randomized, double-blind, placebo-controlled trial
Ishiguro, Naoki
Yamamoto, Kazuhiko
Katayama, Kou
Kondo, Masakazu
Sumida, Takayuki
Mimori, Tsuneyo
Soen, Satoshi
Nagai, Kota
Yamaguchi, Tomonobu
Hara, Masako
MODERN RHEUMATOLOGY, 2013, 23 (03) : 430 - 439
[18] Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate - A randomized, double-blind, placebo-controlled trial
Kremer, JM
Genovese, MC
Cannon, GW
Caldwell, JR
Cush, JJ
Furst, DE
Luggen, ME
Keystone, E
Weisman, MH
Bensen, WM
Kaine, JL
Ruderman, EM
Coleman, P
Curtis, DL
Kopp, EJ
Kantor, SM
Waltuck, J
Lindsley, HB
Markenson, JA
Strand, V
Crawford, B
Fernando, I
Simpson, K
Bathon, JM
ANNALS OF INTERNAL MEDICINE, 2002, 137 (09) : 726 - 733
[19] Randomized, Double-blind, Placebo-controlled, Comparative Study of Human Anti-TNF Antibody Adalimumab in Combination with Methotrexate and Methotrexate Alone in Taiwanese Patients with Active Rheumatoid Arthritis
Chen, Der-Yuan
Chou, Show-Jan
Hsieh, Tsu-Yi
Chen, Yi-Hsing
Chen, Hsin-Hua
Hsieh, Chia-Wei
Lan, Joung-Liang
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2009, 108 (04) : 310 - 319
[20] Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trial
Arora, S
Katkov, W
Cooley, J
Kemp, JA
Johnston, DE
Schapiro, RH
Podolsky, D
HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1724 - 1729

← 1 2 3 4 5 →